BBOT

BridgeBio Oncology
BBOT

31 hedge funds and large institutions have $186M invested in BridgeBio Oncology in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.23M
2
+$3.04M
3
+$1.72M
4
SCM
Silverarc Capital Management
Massachusetts
+$1.13M
5
KPF
K2 Principal Fund
Ontario, Canada
+$1.13M

Top Sellers

1
-$5.25M
2
-$3.67M
3
-$2.63M
4
GPP
Great Point Partners
Connecticut
-$1.43M
5
PA
Perceptive Advisors
New York
-$1.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$32.9M
2
$16.9M
3
$16M
4
$15.8M
5
$12.4M
6
$12.1M
7
$9.04M
8
$6.93M
9
$6.78M
10
$5.95M
11
$5.31M
12
$4.5M
13
$4.5M
14
$4.23M
15
$4.22M
16
$3.39M
17
$2.83M
18
$2.71M
19
$2.27M
20
$2.14M
21
$2.12M
22
$2.09M
23
$1.72M
24
$1.7M
25
$1.64M
1
2